Nystatin
NDC 72189-046
Product Information
Nystatin is a ANDA-approved product labeled by Direct_rx. Nystatin is used to treat fungal skin infections. It is supplied as a yellow product. This product entry covers the primary NDC 72189-046 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 72189-046?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- NYSTATIN (UNII: BDF1O1C72E)
- NYSTATIN (UNII: BDF1O1C72E) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
- CETEARETH-15 (UNII: 867H4YOZ8Z)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- WATER (UNII: 059QF0KO0R)
- DIMETHICONE (UNII: 92RU3N3Y1O)
- SORBITOL (UNII: 506T60A25R)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)
- METHYLPARABEN (UNII: A2I8C7HI9T)
- PETROLATUM (UNII: 4T6H12BN9U)
- PROPYLPARABEN (UNII: Z8IX2SC1OH)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 543546 - nystatin 100,000 UNT/GM Topical Cream
- RxCUI: 543546 - nystatin 100000 UNT/ML Topical Cream
* Please review the full disclaimer at the bottom of this page.
Patient Education
Nystatin Topical
Topical nystatin is used to treat fungal infections of the skin. Nystatin is in a class of antifungal medications called polyenes. It works by stopping the growth of fungi that cause infection.
[Learn More]
* Please review the full disclaimer at the bottom of this page.